ClinicalTrials.gg
RecruitingNCT07209423Updated Aug 31, 2026

Shoulder Strength in Baseball Players

An observational study in Healthy Subjects, sponsored by Loma Linda University. Recruiting at 1 site in United States. Open to participants aged 15 Years to 22 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-31.

Sponsored by Loma Linda University · Observational

From the registry’s dates

  • Started Apr 2026; still recruiting 6 months later.
Study type
Observational
Model
Other
Time perspective
Other
Enrollment
120
Ages
15 Years to 22 Years
Sex
All
01

Study summary

The purpose of this graduate student research study is to transform the existing concepts surrounding shoulder strength in baseball players, particularly in the context of retroverted shoulders.

Read the detailed description

The study aims to investigate the influence of biological age on shoulder strength in comparison to chronological age, providing insights into how these factors might interact in the context of athletic performance. Additionally, the investigators seek to develop a novel framework for injury prevention in baseball, addressing the critical research gap identified in the scope review. Furthermore, the investigators will conduct a comparative analysis between two different countries to deepen the understanding of baseball-related injuries, ultimately fostering a more comprehensive approach to athlete safety and health in the sport.

02

Conditions studied

  • Healthy Subjects

Keywords

  • baseball
  • shoulder
03

In context

Lead sponsor

Loma Linda University is the lead sponsor of 306 studies on the registry; 46 are open to participants now.

Of its 29 completed or terminated interventional studies of FDA-regulated products, 23 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 22 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Baseball players from schools in the United States and Japan.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Able to participate in baseball activities
  • All races and ethnicities.
  • Speaks and understands English or Japanese.

Exclusion criteria

Exclusion Criteria:

A diagnosis of a current injury that prevents participation in baseball activities.

  • Orthopedic conditions (e.g., muscle strain, ligament sprain)
  • Vascular history (e.g., blood clots, vascular surgery, varicose veins)
  • Neurological history (e.g., stroke, nerve injury, or cognitive impairment)
  • Cardiopulmonary conditions (e.g., hypertension, heart disease)
  • Any history of bleeding or clotting disorders
  • Diabetes, cancer, rhabdomyolysis, or compartment syndrome
  • Additionally, not maintaining participant's regular diet on the day of the research will also impact eligibility.
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • Baseball players in the United States

    Other: Strength and Range of Motion

  • Baseball players in Japan

    Other: Strength and Range of Motion

Interventions

  • OtherStrength and Range of Motion

    Shoulder external rotation and internal rotation strength will be measured with a dynamometer at the end range, as well as at retroverted shoulder neutral and zero degrees for three times. Grip strength will also be measured three times using the dynamometer after the shoulder strength assessments.

06

What researchers measure

Primary outcomes

  1. Strength

    Shoulder external rotation and internal rotation strength will be measured with a dynamometer at the end range, as well as at retroverted shoulder neutral and zero degrees for three times. Grip strength will also be measured three times using the dynamometer after the shoulder strength assessments.

    Time frame: baseline reading on visit one

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07209423
Responsible party
Sponsor
First posted
Oct 7, 2025
Start date
Apr 23, 2026
Primary completion
Apr 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Aug 31, 2026

Study contacts

Everett Lohman, DSc
Contact
elohman@llu.edu
909) 558-1000 Ext. 83171
Everett Lohman, DSc
principal investigator · Loma Linda University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion